NBIX icon

Neurocrine Biosciences

231 hedge funds and large institutions have $3.86B invested in Neurocrine Biosciences in 2016 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 67 increasing their positions, 96 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
231
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$82.9M
Puts
$13.9M
Net Calls
Net Calls Change

Top Sellers

1 -$84.2M
2 -$58.1M
3 -$39.9M
4
O
OrbiMed
New York
-$38.1M
5
Invesco
Invesco
Georgia
-$35.4M
Name Holding Trade Value Shares
Change
Change in
Stake
176
$399K
177
$395K
178
$391K
179
$353K
180
$344K
181
$321K
182
$318K
183
$318K
184
$300K
185
$298K
186
$294K
187
$284K
188
$268K
189
$242K
190
$241K
191
$223K
192
$221K
193
$219K
194
$214K
195
$210K
196
$205K
197
$182K
198
$145K
199
$109K
200
$108K